Literature DB >> 21201914

1,4-Dihydroxy-quinoxaline-2,3(1H,4H)-dione.

Rajab Abu-El-Halawah, Basem Fares Ali, Mohammad M Ibrahim, Jalal A Zahra, Wolfgang Frey.   

Abstract

The asymmetric unit of the title compound, C(8)H(6)N(2)O(4), contains one half-mol-ecule; a twofold n class="Disease">rotation axis bisects the molecule. The quinoxaline ring is planar, which can be attributed to electron delocalization. In the crystal structure, inter-molecular O-H⋯O hydrogen bonds link the mol-ecules into R(2) (2)(10) motifs, leading to layers, which inter-act via phen-yl-phenyl inter-actions (C⋯C distances in the range 3.238-3.521 Å).

Entities:  

Year:  2008        PMID: 21201914      PMCID: PMC2960817          DOI: 10.1107/S1600536808003784

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background, see: Zarranz et al. (2004 ▶); Chowdhury et al. (2004 ▶); Monge et al. (1995 ▶); Fuchs et al. (2001 ▶); Dance (1996 ▶); Bernstein et al. (1995 ▶). For related literature, see: Elina & Tsyrul’nikova (1963 ▶); Akkurt et al. (2004 ▶); Mustaphi et al. (2001 ▶); Oxtoby et al. (2005 ▶); Ley & Seng (1975 ▶); For bond-length data, see: Allen et al. (1987 ▶);

Experimental

Crystal data

C8H6N2O4 M = 194.15 Orthorhombic, a = 4.2562 (6) Å b = 17.630 (3) Å c = 10.4775 (17) Å V = 786.2 (2) Å3 Z = 4 Mo Kα radiation μ = 0.14 mm−1 T = 294 (2) K 0.50 × 0.20 × 0.10 mm

Data collection

Nicolet P3 diffractometer Absorption correction: none 1004 measured reflections 529 independent reflections 437 reflections with I > 2σ(I) R int = 0.022 3 standard reflections every 50 reflections intensity decay: 2%

Refinement

R[F 2 > 2σ(F 2)] = 0.034 wR(F 2) = 0.071 S = 1.07 529 reflections 69 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.12 e Å−3 Δρmin = −0.15 e Å−3 Data collection: P3/PC Data Collection Software (Siemens, 1991 ▶); cell refinement: P3/PC Data Collection Software; data reduction: SHELXTL-Plus (Sheldrick, 2008 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL-Plus; software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2003 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536808003784/hk2425sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536808003784/hk2425Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C8H6N2O4F000 = 400
Mr = 194.15Dx = 1.640 Mg m3
Orthorhombic, C2221Mo Kα radiation λ = 0.71073 Å
Hall symbol: C 2c 2Cell parameters from 20 reflections
a = 4.2562 (6) Åθ = 14–16º
b = 17.630 (3) ŵ = 0.14 mm1
c = 10.4775 (17) ÅT = 294 (2) K
V = 786.2 (2) Å3Plates, colourless
Z = 40.50 × 0.20 × 0.10 mm
Nicolet P3 diffractometerRint = 0.022
Radiation source: fine-focus sealed tubeθmax = 27.0º
Monochromator: graphiteθmin = 2.3º
T = 294(2) Kh = 0→5
Wyckoff scank = 0→22
Absorption correction: nonel = −13→13
1004 measured reflections3 standard reflections
529 independent reflections every 50 reflections
437 reflections with I > 2σ(I) intensity decay: 2%
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH atoms treated by a mixture of independent and constrained refinement
R[F2 > 2σ(F2)] = 0.034  w = 1/[σ2(Fo2) + (0.0208P)2 + 0.4073P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.071(Δ/σ)max < 0.001
S = 1.07Δρmax = 0.12 e Å3
529 reflectionsΔρmin = −0.15 e Å3
69 parametersExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.013 (2)
Secondary atom site location: difference Fourier map
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N10.2116 (4)0.41727 (11)0.15388 (16)0.0350 (5)
C10.1130 (6)0.48556 (11)0.1948 (2)0.0364 (6)
O10.4527 (4)0.41624 (10)0.06569 (15)0.0456 (5)
H10.357 (7)0.4338 (15)−0.012 (3)0.072 (10)*
C20.1068 (5)0.34702 (11)0.2004 (2)0.0332 (5)
O20.1965 (5)0.54622 (9)0.14878 (15)0.0531 (6)
C30.2131 (7)0.27901 (13)0.1487 (2)0.0456 (7)
H30.35410.27880.08080.055*
C40.1046 (7)0.21177 (13)0.2002 (2)0.0557 (8)
H40.17450.16590.16690.067*
U11U22U33U12U13U23
N10.0369 (10)0.0401 (9)0.0279 (8)0.0022 (10)0.0011 (9)−0.0011 (8)
C10.0452 (15)0.0371 (12)0.0269 (10)−0.0036 (11)−0.0014 (13)−0.0019 (9)
O10.0416 (9)0.0631 (10)0.0320 (8)0.0113 (10)0.0045 (9)0.0052 (9)
C20.0354 (14)0.0334 (10)0.0309 (10)0.0004 (10)−0.0096 (12)−0.0007 (8)
O20.0823 (16)0.0374 (8)0.0397 (9)−0.0123 (10)0.0136 (13)0.0017 (7)
C30.0519 (16)0.0435 (13)0.0415 (13)0.0099 (13)−0.0118 (16)−0.0077 (10)
C40.072 (2)0.0336 (11)0.0615 (16)0.0086 (13)−0.0242 (18)−0.0079 (11)
N1—C11.345 (3)C2—C2i1.381 (4)
N1—O11.381 (2)C2—C31.391 (3)
N1—C21.404 (3)C3—C41.382 (3)
C1—O21.226 (3)C3—H30.9300
C1—C1i1.503 (4)C4—C4i1.372 (6)
O1—H10.96 (3)C4—H40.9300
C1—N1—O1117.21 (19)C2i—C2—N1118.08 (11)
C1—N1—C2125.42 (18)C3—C2—N1121.5 (2)
O1—N1—C2117.18 (18)C4—C3—C2118.6 (2)
O2—C1—N1124.4 (2)C4—C3—H3120.7
O2—C1—C1i119.22 (14)C2—C3—H3120.7
N1—C1—C1i116.41 (12)C4i—C4—C3120.93 (16)
N1—O1—H1104.2 (17)C4i—C4—H4119.5
C2i—C2—C3120.47 (15)C3—C4—H4119.5
O1—N1—C1—O28.8 (3)C1—N1—C2—C3177.4 (2)
C2—N1—C1—O2−176.4 (2)O1—N1—C2—C3−7.8 (3)
O1—N1—C1—C1i−170.8 (2)C2i—C2—C3—C4−1.1 (4)
C2—N1—C1—C1i4.1 (4)N1—C2—C3—C4178.9 (2)
C1—N1—C2—C2i−2.5 (4)C2—C3—C4—C4i0.3 (5)
O1—N1—C2—C2i172.3 (2)
D—H···AD—HH···AD···AD—H···A
O1—H1···O2ii0.96 (3)1.63 (3)2.584 (2)174 (3)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O1—H1⋯O2i0.96 (3)1.63 (3)2.584 (2)174 (3)

Symmetry code: (i) .

  6 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).

Authors:  T Fuchs; G Chowdhury; C L Barnes; K S Gates
Journal:  J Org Chem       Date:  2001-01-12       Impact factor: 4.354

3.  Water superstructures within organic arrays; hydrogen-bonded water sheets, chains and clusters.

Authors:  Neil S Oxtoby; Alexander J Blake; Neil R Champness; Claire Wilson
Journal:  Chemistry       Date:  2005-08-05       Impact factor: 5.236

4.  Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.

Authors:  A Monge; J A Palop; A López de Ceráin; V Senador; F J Martínez-Crespo; Y Sainz; S Narro; E García; C de Miguel; M González
Journal:  J Med Chem       Date:  1995-05-12       Impact factor: 7.446

5.  Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.

Authors:  Belén Zarranz; Andrés Jaso; Ignacio Aldana; Antonio Monge
Journal:  Bioorg Med Chem       Date:  2004-07-01       Impact factor: 3.641

6.  Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxide.

Authors:  Goutam Chowdhury; Delshanee Kotandeniya; J Scott Daniels; Charles L Barnes; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2004-11       Impact factor: 3.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.